Precision oncology offerings from JAX Clinical Education
Precision oncology offerings from JAX Clinical Education
5 Things to Know About Biomarker Testing. 30-minute webinar highlights the key benefits and limitations of various cancer biomarker tests.
ABCs of HRD: Understanding Homologous Recombination Deficiency. 30-minute webinar explains the various terms and biomarkers associated with HRD testing.
Biomarker Testing for Targeted Therapy FAQ. Describes large panel genomic tumor testing and discusses its benefits, risks, and limitations.
Comparing Cancer Biomarker Tests. Provides information about how cancer biomarker test offerings may differ among laboratories.
Exploring Cancer Biomarker Testing. Learn about benefits, limitations, and challenges of using large somatic cancer panels. Free, self-directed program for continuing education credit.
Financial considerations of genomic tumor testing. Help clinicians discuss costs of genomic tumor testing and targeted treatments with their patients, including ways to find financial support.
Immunotherapy Biomarkers. Provides an overview of the benefits and limitations of commonly used immune checkpoint inhibition biomarkers.
Liquid Biopsy Testing FAQ. Describes the benefits, risks and limitations of liquid biopsy.
Three things to know about genomic tumor test selection. Discusses considerations for choosing the most appropriate genomic tumor test for a patient.
Understanding Biomarker Testing: Types, Benefits & Limitations. Defines and compares benefits and limitations of types of biomarker testing for identifying targeted treatments.
When is pharmacogenomic testing useful in cancer care? Discusses utility of pharmacogenomic testing in cancer care.
Assessing Biomarker Testing Results to Inform Treatment. Provides a framework for assessing the evidence supporting targeted treatment options.
Cancer Biomarker Report Terms. Explains common terms used in cancer biomarker test reports.
Exploring Cancer Biomarker Testing. Learn about benefits, limitations, and challenges of using large somatic cancer panels.
Germline Testing After Biomarker Testing: When and Why? 30-minute webinar highlights indications for hereditary cancer testing after cancer biomarker testing.
Hereditary Cancer Genes. Lists genes that are associated with hereditary cancer and should be considered for referral when identified on a tumor test report.
Hereditary Cancer Syndromes: Are your Patients at Risk? Develop skills and knowledge to identify those patients most appropriate for genetic testing, choosing the right test, and using the results to develop a management plan. Free, self-directed program.
Homologous Recombination Deficiency (HRD) Testing: FAQs. Provides an overview of biomarkers included in HRD testing.
How to Maximize the Genomic Tumor Board Experience. Suggests ways for you to make the most of the genomic tumor board experience.
Indications for Genetic Testing for Inherited Cancer Risk After Biomarker Testing. Provides a quick reference about the factors to consider when determining the appropriateness of germline testing.
Interpreting Cancer Biomarker Testing for Genetic Counselors. Practice evaluating biomarker test reports to determine when genetic testing for hereditary cancer risk is indicated for a patient.
Multidisciplinary Expert Insights: Assessing Hereditary Cancer Risks for Genomic Tumor Testing. A multidisciplinary panel of clinical and laboratory experts discusses a case that highlights factors relevant for the interpretation of tumor results for hereditary risks.
Multidisciplinary Expert Insights: Navigating DNA Damage Repair Deficiency in Cancer Patient Management. A multidisciplinary panel of clinical experts discusses a case that involves DNA repair deficiency and PARP inhibitors, including BRCA1/2 and other biomarkers, and how to make informed decisions regarding the best path forward for the patient.
Red Flags to Consider Additional Cancer Biomarker Testing. Provides a quick reference for the factors that may warrant further cancer biomarker testing
Understanding variants of uncertain significance in somatic cancer panel testing. Describes reasons a genomic variant can have uncertain significance when identified in a tumor.
Accessing Off-Label Drugs and Experimental Treatments for Cancer Patients. Provides guidance on how to access off-label drugs and experimental treatments for cancer patients.
How do I get from here to there? Navigating precision medicine in cancer. Discusses the role of a genomics navigator to help navigate genetic and genomic testing for cancer patients.
How to Maximize the Genomic Tumor Board Experience. Suggests ways for you to make the most of the genomic tumor board experience.
Immunotherapy - implications for patients with mismatch repair deficient tumors. Discussion of how precision medicine brings personalized treatment options to patients with mismatch repair deficient tumors.
Accessing Genetic Services. Lists tools and websites to help find genetic professionals and provides patient talking points about referring to genetics.
Communicating with patients about somatic tumor testing. Provides communication messages about the decision to undergo somatic tumor testing.
Facilitating Shared Decision-Making About Genomic Tumor Testing. Supports clinicians when communicating about the process, benefits, and limitations of genomic tumor testing.
Understanding Biomarker Testing. Content for patients to learn about biomarker testing, its role in cancer care, and how it helps guide personalized treatment options.
Understanding Cancer Genetic Testing. Content for patients to learn more about cancer genetic testing’s role in detecting and assessing risk for certain cancers.
Understanding Cancer Treatments. Content for patients to learn more about different approaches to treating cancer and how they work.
Understanding Clinical Trials. Content for patients to learn more about cancer research studies and if one is right for them.